Jun 6, 2014
Swing Trade Ideas for Friday, June 6: Celldex, Two Others
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Thursday's ETF Movers: XBI, EWD
In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 2.8% on the day.
Celldex Therapeutics' Varlilumab Continues to Demonstrate Very Favorable Profile
Celldex Therapeutics, Inc. today reported data from its ongoing Phase 1 study of the fully human monoclonal antibody varlilumab in cancer.
Oncothyreon and Celldex Therapeutics Announce Collaboration for...
Oncothyreon Inc. and Celldex Therapeutics, Inc., today announced that they have agreed to collaborate on a combined clinical trial of ONT-10 and varlilumab.
Celldex volatility elevated into ASCO
Celldex CDX-1127 data positive, says Oppenheimer After analyzing ASCO abstracts, Oppenheimer thinks the data indicated that Celldex's CDX-1127 is well-tolerated and capable of inducing an immune response.